Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | GNG5 |
| Upstream (Parents) |
|---|
| (<<) ANXA2 → GNG5 |
| (<<) CDC42EP2 → GNG5 |
| (<<) CHAF1A → GNG5 |
| (<<) CSNK1A1 → GNG5 |
| (<<) DUSP2 → GNG5 |
| (<<) GPX1 → GNG5 |
| (<<) HSPA14 → GNG5 |
| (<<) ITPR1 → GNG5 |
| (<<) KLF16 → GNG5 |
| (<<) MAP3K11 → GNG5 |
| (<<) MAPK8 → GNG5 |
| (<<) PPIB → GNG5 |
| (<<) TPP1 → GNG5 |
| (<<) TRAF2 → GNG5 |
| (<<) TXNIP → GNG5 |
| Downstream (Children) |
|---|
| GNG5 → BCAR3 (>>) |
| GNG5 → E2F6 (>>) |
| GNG5 → GSK3B (>>) |
| GNG5 → HDAC8 (>>) |
| GNG5 → ILDR1 (>>) |
| GNG5 → LARP6 (>>) |
| GNG5 → MAP6D1 (>>) |
| GNG5 → PTEN (>>) |
| GNG5 → RPL26L1 (>>) |
| GNG5 → RPS14 (>>) |
| GNG5 → RXRA (>>) |
| GNG5 → SH3GLB1 (>>) |
| GNG5 → SPATA2L (>>) |
| GNG5 → STAT6 (>>) |
| GNG5 → STK40 (>>) |
| GNG5 → TINF2 (>>) |
| GNG5 → TPM3 (>>) |
| GNG5 → UBE2E3 (>>) |
| GNG5 → VANGL1 (>>) |
